Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans

American Journal of the Medical Sciences

Volumn 337, Issue 2, 2009, Pages 98-102

  Kim, Hong Kyu ^a   Park, Joong Yeol ^a   Lee, Ki Up ^a   Lee, Go Eun ^a   Jeon, Seong Hoon ^a   Kim, Jin Ho ^a   Kim, Chul Hee ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Body weight change; Korean; Long term course; Nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; KOREA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD PRESSURE; DIET THERAPY; LIFESTYLE; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; BLOOD PRESSURE; BODY WEIGHT; FATTY LIVER; FEMALE; HUMANS; KOREA; LIFE STYLE; LIVER FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; WEIGHT LOSS; YOUNG ADULT;

EID: 61849158207     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181812879     Document Type: Article

References (33)

1. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44-52. (Pubitemid 40911310)
2. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-1395 (Pubitemid 39657013)
3. Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40:745-752
4. Cortez-Pinto H, Camilo ME, Baptista A, et al. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999;18: 353-358
5. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37: 917-923 (Pubitemid 36397405)
6. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-1231
7. Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-873 (Pubitemid 46489550)
8. Dam-Larsen S, Franzmann M, Andersen IB, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004;53:750-755 (Pubitemid 38561456)
9. Jepsen P, Vilstrup H, Mellemkjaer L, et al. Prognosis of patients with a diagnosis of fatty liver-a registry-based cohort study. Hepatogastroenterology 2003;50:2101-2104 (Pubitemid 37468003)
10. Clark JM. Weight loss as a treatment for nonalcoholic fatty liver disease. J Clin Gastroenterol 2006;40:S39-S43. (Pubitemid 44309542)
11. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82:315-322 (Pubitemid 43780662)
12. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-107 (Pubitemid 27357062)
13. Mendez-Sanchez N, Gonzalez V, Chavez-Tapia N, et al. Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial. Ann Hepatol 2004;3:108-112
14. Zelber-Sagi S, Kessler A, Brazowsky E, et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006;4:639-644
15. Wang RT, Koretz RL, Yee HF Jr. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med 2003;115:554-559
16. Mittelstaedt CA. General ultrasound, 1st ed. Edinburgh: Churchill Livingstone; 1992. p. 184-186
17. Suzuki A, Lindor K, St Saver J, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060-1066 (Pubitemid 41627993)
18. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006;16:1278-1286
19. Stratopoulos C, Papakonstantinou A, Terzis I, et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 2005;15:1154-1160 (Pubitemid 41390214)
20. Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 2005;242:610-617. (Pubitemid 41428657)
21. Mottin CC, Moretto M, Padoin AV, et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005;15:788-793 (Pubitemid 40904867)
22. Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc 2006;81:S46-S51. (Pubitemid 44484964)
23. Siebler J, Galle PR. Treatment of nonalcoholic fatty liver disease. World J Gastroenterol 2006;12:2161-2167
24. Thomas EL, Brynes AE, Hamilton G, et al. Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 2006;12:5813-5819. (Pubitemid 44594249)
25. Petersen KF, Dufour S, Befroy D, et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005;54:603-608 (Pubitemid 40322060)
26. Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11: 74-80. (Pubitemid 20075105)
27. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042-2047 (Pubitemid 37185803)
28. Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-138
29. Hui AY, Wong VW, Chan HL, et al. Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment Pharmacol Ther 2005;21:407-413. (Pubitemid 40313943)
30. Strauss S, Gavish E, Gottlieb P, et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR 2007;189: W320-W323. (Pubitemid 350174809)
31. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123: 745-750 (Pubitemid 34977081)
32. D'Onofrio M, Martone E, Brunelli S, et al. Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis. Radiol Med (Torino) 2005;110:341-348 (Pubitemid 43028137)
33. Shen L, Li JQ, Zeng MD, et al. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol 2006;12:1292-1295